Controlled release of nerve growth factor from fibrin gel

被引:38
作者
Bhang, Suk Ho
Jeon, Oju
Choi, Cha Yong
Kwon, Yun Hee Kim
Kim, Byung-Soo [1 ]
机构
[1] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea
[2] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151742, South Korea
[3] Kyung Hee Univ, Dept Biol, Seoul 130701, South Korea
关键词
nerve growth factor; controlled release; fibrin gel; pheochromocytoma cell;
D O I
10.1002/jbm.a.31050
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Nerve growth factor (NGF) is known to promote the axonal regeneration in injured nerve system. Delivery of NGF for a long period in a controlled manner may enhance the regeneration efficacy. In this study, we investigated whether NGF can be released from fibrin gel for a long period in a controlled manner. We also investigated whether sustained delivery of NGF using fibrin gel can enhance the efficacy of NGF in vitro. The addition of heparin to fibrin gel decreased the rate of NGF release from the fibrin gel. As the concentrations of thrombin and fibrinogen in fibrin gel increased, the NGF release rate decreased significantly, and the initial release burst decreased. NGF was released for up to 14 days in vitro. The bioactivity of NGF released from fibrin gel was assessed by morphological changes of pheochromocytoma (PC12) cells cultured in the presence of NGF-containing fibrin gel. NGF released from fibrin gel exhibited significantly higher degrees of PC12 cell viability and differentiation than NGF added in a free form daily into the culture medium. This study demonstrates that fibrin gel can release NGF in a sustained, controlled manner and in a bioactive form. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:998 / 1002
页数:5
相关论文
共 22 条
[1]   Characterization of a fibrin glue-GDNF slow-release preparation [J].
Cheng, HR ;
Fraidakis, M ;
Blomback, B ;
Lapchak, P ;
Hoffer, B ;
Olson, L .
CELL TRANSPLANTATION, 1998, 7 (01) :53-61
[2]   Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs [J].
Emanueli, C ;
Salis, MB ;
Pinna, A ;
Graiani, G ;
Manni, L ;
Mededdu, P .
CIRCULATION, 2002, 106 (17) :2257-2262
[3]   ESTABLISHMENT OF A NORADRENERGIC CLONAL LINE OF RAT ADRENAL PHEOCHROMOCYTOMA CELLS WHICH RESPOND TO NERVE GROWTH-FACTOR [J].
GREENE, LA ;
TISCHLER, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (07) :2424-2428
[4]   Stable hepatocyte transplantation using fibrin matrix [J].
Gwak, SJ ;
Choi, DH ;
Paik, SS ;
Lee, EY ;
Lee, KS ;
Kim, BS .
BIOTECHNOLOGY LETTERS, 2004, 26 (06) :505-508
[5]   NERVE GROWTH-FACTOR PROMOTES CNS CHOLINERGIC AXONAL REGENERATION INTO ACELLULAR PERIPHERAL-NERVE GRAFTS [J].
HAGG, T ;
GULATI, AK ;
BEHZADIAN, MA ;
VAHLSING, HL ;
VARON, S ;
MANTHORPE, M .
EXPERIMENTAL NEUROLOGY, 1991, 112 (01) :79-88
[6]   Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin [J].
Jeon, O ;
Ryu, SH ;
Chung, JH ;
Kim, BS .
JOURNAL OF CONTROLLED RELEASE, 2005, 105 (03) :249-259
[7]  
KERKHOFF H, 1993, CLIN NEUROL NEUROSUR, V95, pS103
[8]   A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling [J].
Kuruvilla, R ;
Zweifel, LS ;
Glebova, NO ;
Lonze, BE ;
Valdez, G ;
Ye, HH ;
Ginty, DD .
CELL, 2004, 118 (02) :243-255
[9]   Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimer's Disease [J].
Lad, Shivanand P. ;
Neet, Kenneth E. ;
Mufson, Elliott J. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (05) :315-334
[10]   Polypeptide growth factors: targeted delivery systems [J].
Nimni, ME .
BIOMATERIALS, 1997, 18 (18) :1201-1225